By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Rosuvastatin

Rosuvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
4 Min Read
SHARE
3 min read|565 words

Rosuvastatin: A Comprehensive Drug Profile

What is Rosuvastatin?

Rosuvastatin is a prescription medication belonging to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in patients with elevated cholesterol or other heart disease risk factors. Rosuvastatin is considered one of the most potent statins available for managing lipid disorders.

Uses

Rosuvastatin is prescribed for several cardiovascular and lipid-related conditions:

  • High cholesterol (hypercholesterolemia): Reduces total cholesterol, LDL (“bad”) cholesterol, and triglycerides while increasing HDL (“good”) cholesterol
  • Primary prevention of cardiovascular disease: Used in patients with multiple risk factors but no existing heart disease to prevent heart attacks and strokes
  • Secondary prevention: Prescribed for patients with existing cardiovascular disease to prevent future cardiac events
  • Familial hypercholesterolemia: Treats inherited conditions causing extremely high cholesterol levels
  • Mixed dyslipidemia: Addresses multiple lipid abnormalities including elevated triglycerides and low HDL cholesterol

How it works

Rosuvastatin works by blocking HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the medication significantly reduces the amount of cholesterol the body produces naturally. This forces the liver to remove more cholesterol from the bloodstream, leading to lower overall cholesterol levels and improved cardiovascular risk profile.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Abdominal pain
  • Nausea
  • Dizziness
  • Constipation
  • Joint pain
  • Memory problems or confusion

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, tenderness, or weakness (potential rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (liver problems)
  • Severe abdominal pain
  • Unexplained fatigue or fever

Warnings and precautions

  • Liver disease: Patients with active liver disease or unexplained elevated liver enzymes should not take rosuvastatin
  • Pregnancy and breastfeeding: Rosuvastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus or infant
  • Kidney impairment: Dosage adjustments may be necessary for patients with severe kidney disease
  • Muscle disorders: Patients with a history of muscle problems or those taking certain medications have increased risk of muscle-related complications
  • Age considerations: Elderly patients, particularly those over 65, may be more susceptible to muscle-related side effects

Interactions

  • Warfarin: May increase bleeding risk by enhancing warfarin’s anticoagulant effects
  • Cyclosporine: Significantly increases rosuvastatin blood levels, requiring dose reduction
  • Gemfibrozil: Increases risk of muscle toxicity when combined with rosuvastatin
  • Antacids: Aluminum and magnesium-containing antacids can reduce rosuvastatin absorption
  • Protease inhibitors: HIV medications like lopinavir/ritonavir can increase rosuvastatin levels
  • Fenofibrate: May increase muscle toxicity risk when used concurrently
  • Niacin (high doses): Can increase risk of muscle problems when combined with statins
  • Red yeast rice: Contains natural statins and may increase risk of side effects

Check interactions with the GMJ Interaction Checker

Dosage

Rosuvastatin is typically taken once daily, with or without food. The usual starting dose for adults ranges from 5-10 mg daily, with maintenance doses typically between 5-40 mg daily depending on the patient’s response and cholesterol targets. For patients with severe kidney disease, the maximum recommended dose is 10 mg daily. Dosage adjustments may be necessary for elderly patients or those taking certain interacting medications. Healthcare providers determine the appropriate dose based on individual patient factors, cholesterol levels, and cardiovascular risk assessment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Rosuvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/rosuvastatin-3/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Lovastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026

Lovastatin

By
GMJ News Desk
01/06/2026

Atorvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up